• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.

作者信息

Mancuso A, De Vivo A, Triolo O, Irato S

机构信息

Department of Gynecological, Obstetrical Sciences and Reproductive Medicine, University of Messina, Messina, Italy.

出版信息

Eur J Gynaecol Oncol. 2004;25(2):207-10.

PMID:15032283
Abstract

PURPOSE OF INVESTIGATION

To evaluate the ability of CA 125 and echography, alone and in combination with clinical parameters (age over 50 years and post-menopausal state), in the diagnosis of a malignant pelvic mass.

METHODS

125 women were enrolled and underwent echography and CA 125 assay. For each methodology, positive and negative predictive value, sensitivity, specificity, diagnostic accuracy, pre- and post-test probability and likelihood ratios were calculated.

RESULTS

Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), diagnostic accuracy (DA) and positive likelihood ratio were identical for echography and CA 125 considered alone. Paired with the patient's age, the CA 125 assay showed better results than the associations echography-age (LR+ 26.9 vs 10.1) or CA 125-echography (LR+ 26.9 vs 17.8). Furthermore the combination of the postmenopausal state with CA 125 obtained the best result of a positive likelihood ratio (LR+ 29.7).

CONCLUSION

Our study pointed out that, in the prediction of a malignant adnexal mass, the best results were obtained from the association between CA 125 and menopause, probably because in this period there is a lower incidence of benign diseases related to this marker so that an increase of CA 125 level is more likely associated with a malignant mass.

摘要

相似文献

1
The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.
Eur J Gynaecol Oncol. 2004;25(2):207-10.
2
Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.评估血清CA-125、CA15-3、CA-19-9、癌胚抗原和甲胎蛋白水平对于鉴别附件肿块良恶性的重要性以及不同检测组合对诊断准确性的贡献。
Eur J Gynaecol Oncol. 2013;34(6):540-4.
3
Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.经阴道彩色多普勒超声检查及CA-125在可疑附件包块中的应用
Int J Gynaecol Obstet. 1999 Sep;66(3):255-61. doi: 10.1016/s0020-7292(99)00104-6.
4
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
Gynecol Oncol. 1998 Apr;69(1):56-63. doi: 10.1006/gyno.1998.4942.
5
The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.卵巢恶性肿瘤诊断中的恶性风险指数(RMI)
Asian Pac J Cancer Prev. 2009;10(5):865-8.
6
Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.盆腔检查、超声及血清CA 125在绝经后盆腔肿块女性中的诊断价值。一项国际多中心研究。
Cancer. 1994 Aug 15;74(4):1398-406. doi: 10.1002/1097-0142(19940815)74:4<1398::aid-cncr2820740433>3.0.co;2-j.
7
[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].[血清人附睾分泌蛋白4及CA125检测在卵巢恶性肿瘤诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):931-6.
8
Risk of malignancy index in preoperative evaluation of pelvic masses.盆腔肿块术前评估中的恶性肿瘤风险指数
Asian Pac J Cancer Prev. 2011;12(7):1727-30.
9
Comparison of pelvic masses score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masses.盆腔肿块评分(PMS)与恶性风险指数(RMI 3)在盆腔肿块评估中的比较。
Eur J Gynaecol Oncol. 2014;35(4):421-4.
10
Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.利用彩色和脉冲多普勒超声以及血清CA - 125、CA - 19.9、CA - 72.4和血管内皮生长因子测量对良性和恶性卵巢肿瘤血管生成的研究。
Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):113-31.

引用本文的文献

1
Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses: A meta-analysis.经阴道超声检查对附件包块进行特定诊断的诊断准确性:一项荟萃分析。
Exp Ther Med. 2020 Dec;20(6):265. doi: 10.3892/etm.2020.9395. Epub 2020 Oct 27.
2
Management of a suspicious adnexal mass: a clinical practice guideline.附件肿物可疑患者的处理:临床实践指南。
Curr Oncol. 2012 Aug;19(4):e244-57. doi: 10.3747/co.19.980.
3
Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.
靶向GIPC1的天然人类自身抗体可识别乳腺癌和卵巢癌中的差异表达。
BMC Cancer. 2008 Aug 24;8:247. doi: 10.1186/1471-2407-8-247.